Most available data comes from observational studies, post-hoc analyses, or research focused on metabolic outcomes in patients who happen to have coexisting inflammatory conditions
Pregnant or Breastfeeding Semaglutides safety during pregnancy or while breastfeeding is not well-established
The medication also improves insulin sensitivity and may preserve lean muscle mass during weight loss, a critical advantage over calorie restriction alone
LEADER trial: Cardiovascular outcomes with liraglutide JAMA Network Open (2022)
To keep patients safe and outcomes strong, consider the following clinical best practices: Start low, go slow on dosing Monitor for GI symptoms, especially early on Revisit mental health and vision concerns routinely Avoid use in patients with thyroid cancer history Stay alert for signs of pancreatitis or gallbladder issues Smart oversight matters
According to Sharath Chandra Guntuku, Research Associate Professor in Computer and Information Science (CIS) at Penn Engineering and the study's senior author, Some of the side effects we found, like nausea, are well known, and that shows that the method is picking up a real signal. The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them, Guntuku added